In the clinical context, aberrations in glycolysis are linked to several diseases. For instance, cancer cells often exhibit increased glycolysis, a phenomenon known as the Warburg effect. This makes glycolysis a target for cancer therapies. Additionally, deficiencies in glycolytic enzymes can lead to metabolic disorders.
